Clinical Trial Update: Phase I/II Study of KRN330 Plus Irinotecan in Patients With Metastatic Colorectal Cancer [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports a Phase 1/2 study of KRN330 in combination with irinotecan for metastatic colorectal cancer, which was terminated and had its…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Irinotecan (Irinotecan)
• KRN330

Snippet

Sponsor: Kyowa Kirin Co., Ltd. | Conditions: Colorectal Cancer | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2015-03-23